Intractable livedoid vasculopathy successfully treated with hyperbaric oxygen

British Journal of Dermatology

Volumn 149, Issue 3, 2003, Pages 647-652

  Yang, C H ^a   Ho, H C ^a   Chan, Y S ^a   Liou, L B ^a   Hong, H S ^a   Yang, L C ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Atrophie blanche; Hyperbaric oxygen; Laser doppler perfusion imaging; Livedo vasculitis; Livedoid vasculopathy

Indexed keywords

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; FEMALE; HUMAN; HYPERBARIC OXYGEN; LABORATORY TEST; LIVEDOID VASCULOPATHY; MALE; PAIN; PERIPHERAL CIRCULATION; PRIORITY JOURNAL; SKIN DEFECT; SKIN ULCER; TISSUE OXYGENATION; TREATMENT OUTCOME; VASCULAR DISEASE;

ADOLESCENT; ADULT; CHRONIC DISEASE; FEMALE; HUMANS; HYPERBARIC OXYGENATION; LEG ULCER; MALE; PAIN; PIGMENTATION DISORDERS; PURPURA; SKIN DISEASES, VASCULAR;

EID: 0142025174     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.2003.05546.x     Document Type: Article

References (34)

1. Stiefler RE, Bergfeld WF. Atrophie blanche. Int J Dermatol 1982; 21: 1-7.
2. Yang LJ, Chan HL, Chen SY et al. Atrophie blanche. A clinico-pathological study of 27 patients. Changgeng Yi Xue Za Zhi 1991; 14: 237-45.
3. Winkelmann RK. Livedoid vasculitis (segmental hyalinizing vasculitis). Jpn J Dermatol B 1972; 82: 84-9.
4. Shornick JK, Nicholes BK, Bergstresser PR et al. Idiopathic atrophie blanche. J Am Acad Dermatol 1983; 8: 792-8.
5. Gilliam JN, Herndon JH, Prystowsky SD. Fibrinolytic therapy for vasculitis of atrophie blanche. Arch Dermatol 1974; 109: 664-7.
6. Kern AB. Atrophie blanche. Report of two patients treated with aspirin and dipyridamole. J Am Acad Dermatol 1982; 6: 1048-53.
7. Sauer GC. Pentoxifylline (Trental) therapy for the vasculitis of atrophie blanche. Arch Dermatol 1986; 122: 380-1.
8. Klein KL, Pittelkow MR. Tissue plasminogen activator for treatment of livedoid vasculitis. Mayo Clin Proc 1992; 67: 923-33.
9. Jetton RL, Lazarus GS. Minidose heparin therapy for vasculitis of atrophie blanche. J Am Acad Dermatol 1983; 8: 23-6.
10. Wakelin SH, Ellis JP, Black MM. Livedoid vasculitis with anticardiolipin antibodies: improvement with danazol. Br J Dermatol 1998; 139: 935-7.
11. Purcell SM, Hayes TJ. Nifedipine treatment of idiopathic atrophie blanche. J Am Acad Dermatol 1986; 14: 851-4.
12. Gupta AK, Goldfarb MT, Voorhees JJ. The use of sulfasalazine in atrophie blanche. Int J Dermatol 1990; 29: 663-5.
13. Lee JH, Choi HJ, Kim SM et al. Livedoid vasculitis responding to PUVA therapy. Int J Dermatol 2001; 40: 153-7.
14. Ravat FE, Evans AV, Russell-Jones R. Response of livedoid vasculitis to intravenous immunoglobulin. Br J Dermatol 2002; 147: 166-9.
15. Kalani M, Jorneskog G, Naderi N et al. Hyperbaric oxygen (HBO) therapy in treatment of diabetic foot ulcers. Long-term follow-up. J Diabetes Complications 2002; 16: 153-8.
16. Tibbles PM, Edelsberg JS. Hyperbaric-oxygen therapy. N Engl J Med 1996; 334: 1642-8.
17. Boyvat A, Kundakci N, Babikir MO et al. Livedoid vasculopathy associated with heterozygous protein C deficiency. Br J Dermatol 2000; 143: 840-2.
18. Biedermann T, Flaig MJ, Sander CA. Livedoid vasculopathy in a patient with factor V mutation (Leiden). J Cutan Pathol 2000; 27: 410-12.
19. Jain KK. Textbook of Hyperbaric Medicine. 2nd edn. Seattle, WA: Hogrefe & Huber Publishers, 1996.
20. Chen CY, Lee SS, Chan YS et al. Chronic refractory tibia osteomyelitis treated with adjuvant hyperbaric oxygen: a preliminary report. Changgeng Yi Xue Za Zhi 1998; 21: 165-71.
21. Tjarnstrom J, Holmdahl L, Falk P et al. Effects of hyperbaric oxygen on expression of fibrinolytic factors of human endothelium in a simulated ischaemia/reperfusion situation. Scand J Clin Lab Invest 2001; 61: 539-45.
22. Yamami N, Shimaya K, Sera AM et al. Alterations of fibrinolytic activity in human during and after hyperbaric oxygen exposure. Appl Human Sci 1996; 15: 239-42.
23. Pizzo SV, Murray JC, Gonias SL. Atrophie blanche. A disorder associated with defective release of tissue plasminogen activator. Arch Pathol Lab Med 1986; 110: 517-19.
24. Heng MC, Harker J, Csathy G et al. Angiogenesis in necrotic ulcers treated with hyperbaric oxygen. Ostomy Wound Manage 2000; 46: 30-2.
25. Knighton DR, Silver IA, Hunt TK. Regulation of wound-healing angiogenesis-effect of oxygen gradients and inspired oxygen concentration. Surgery 1981; 90: 262-70.
26. Marx RE, Ehler WJ, Tayapongsak P et al. Relationship of oxygen dose to angiogenesis induction in irradiated tissue. Am J Surg 1990; 160: 519-24.
27. 2 tension on microbicidal function of leukocytes in wounds and in vitro. Surg Forum 1976; 27: 18-20.
28. Tompach PC, Lew D, Stoll JL. Cell response to hyperbaric oxygen treatment. Int J Oral Maxillofac Surg 1997; 26: 82-6.
29. Roberts GP, Harding KG. Stimulation of glycosaminoglycan synthesis in cultured fibroblasts by hyperbaric oxygen. Br J Dermatol 1994; 131: 630-3.
30. Zamboni WA, Roth AC, Russell RC et al. Morphologic analysis of the microcirculation during reperfusion of ischemic skeletal muscle and the effect of hyperbaric oxygen. Plast Reconstr Surg 1993; 91: 1110-23.
31. Droog EJ, Steenbergen W, Sjoberg F. Measurement of depth of burns by laser Doppler perfusion imaging. Burns 2001; 27: 561-8.
32. Anderson ME, Moore TL, Hollis S et al. Digital vascular response to topical glyceryl trinitrate, as measured by laser Doppler imaging, in primary Raynaud's phenomenon and systemic sclerosis. Rheumatology (Oxford) 2002; 41: 324-8.
33. Bornmyr S, Martensson A, Svensson H et al. A new device combining laser Doppler perfusion imaging and digital photography. Clin Physiol 1996; 16: 535-41.
34. Jiang L, Gu Y, Li X et al. Changes of skin perfusion after photodynamic therapy for port wine stain. Chin Med J (Engl) 1998; 111: 136-8.